FDA Reports Latest List of Potentially Risky Drugs

The FDA has just released its quarterly Potential Signals of Serious Risks/New Safety Information Identified from the Adverse Event Reporting System (AERS) between July - September 2008. The FDA has identified potential safety issues, but this does not mean that FDA has identified a causal relationship between the drug and the listed risk. I've listed the July - Sept '08 list of affected drugs here . . . Product Name: Active Ingredient (Trade) or Product Class (Potential Signal of Serious Risk/New Safety Information)

1. Codeine-containing cough medicine (Adverse events in children)
2. Oral bisphosphonates (Esophageal cancer)
3. Mefloquine HCl (Lariam)(Psychiatric events)
4. Minocycline (Thyroid disorders)
5. Bupivicaine intraarticular injection given by infusion pump (Chondrolysis)
6. Selective serotonin and selective norepinephrine reuptake Inhibitors (SSRI and SNRI) antidepressants (Birth defects)
7. Propylthiouracil and Methimazole (Hepatotoxicity)
8. Phenytoin injection (Cardiac arrest due to rapid injectionK)
9. Terbinafine (Lamisil) oral use (Psychiatric events)

For more complete FDA information: Potential Signals of Serious Risks/New Safety Information Identified from the Adverse Event Reporting System (AERS) Quarterly Reports 2008 January to March 2008 April to June 2008 July to September

Return Home: http://drughealth.blogspot.com/